Australian Cardiovascular Alliance

Cardiovascular research benefiting all Australians

The Australian Cardiovascular Alliance (ACvA) is the peak leadership body in the country for the advancement of heart, stroke and vascular disease research.

It is a comprehensive collaboration of the very highest quality cardiovascular research bodies and scientific societies, individual researchers, industry and non-government organisations in Australia and is uniquely positioned to leverage key interactions between Australia’s strong research capability and the health system to improve health outcomes and reduce costs.


A Snapshot of Australia’s Cardiovascular Health


1 in 4 deaths in Australia are from CV disease, killing one Australian every 13 minutes.


At $10.4 billion annually, CV disease is Australia’s highest disease expenditure.


Atherosclerosis is the major underlying cause of CV disease and contributes significantly to heart attacks and strokes.


Heart failure will affect 20% of adults in their lifetime.


56,000 strokes in Australia in 2017; 65% of survivors are unable to carry out daily living activities unassisted.


One Australian limb lost every
2 hours due to complications of diabetes and peripheral arterial disease.


1.1 million hospitalisation for CV in 2016-17 accounting for 11% of all hospitalisation.


CVD disease disproportionately affects indigenous, remote and socioeconomically disadvantaged Australians.


The ACvA institutes and societies bring expertise that spans fundamental biomedical research through to global clinical trial and public health bodies.

We work in partnership with the Heart Foundation, and industry members committed to the improvement of cardiovascular health in Australia. We are deeply engaged with the NH&MRC-recognised Australian Health and Research Translational Centres and extend into primary care, which is essential for health impact.


As a member-driven organisation, the ACvA believes the time is ripe for a new vision, new thinking and new strategies to solve cardiovascular disease.

We have developed a strong case for investment in cardiovascular health that represents a step change for cardiovascular health, bringing together our entire cardiovascular research community and promoting a whole-of-nation approach along a bi-directional translational pipeline. This will ensure that our talented researchers are aligned to the most urgent clinical challenges and that discoveries and innovative approaches to care are translated to the bedside in an accelerated manner. These ambitious objectives can only be met through significant investment, leadership and collaboration.

ACvA Latest News

Including MRFF Grant Recipients

The first round of MRFF grant funding resulted in $29 million invested by the government towards tackling our nation’s single biggest killer. In order to celebrate the success, the ACvA is featuring one grant recipient each day for the week.

MRFF funding success!

MRFF funding success!

The first round of MRFF grant funding announced by the Federal Minister for Health resulted in $29 million invested towards tackling our nation’s single biggest killer. In order to celebrate the success, ACvA hosted a spotlight on grant recipients over the course of a...

read more
Oz Hearts Song Contest!

Oz Hearts Song Contest!

ACvA is very pleased to launch an exciting new program – the OZHEARTS SONG CONTEST, to raise awareness of the important role research is playing to help make heart disease history. We look forward to hearing from our talented artists to help us spread this message....

read more
Scholarship Alert!

Scholarship Alert!

The University of Sydney has recently opened a new scholarship for prospective PhD students undertaking cardiovascular research. This scholarship is eligible for domestic students commencing a full-time PhD within the Faculty of Medicine and Health at the University...

read more

ACvA Latest Video

ACvA Latest Tweets

Congratulations @LiviaHool this is brilliant news @OzCvA

The @heartfoundation strategic grants for cardio-oncology and predictive modelling open Monday 6 July 10am AEST.

Visit the site below for more details and to apply:

#FRIDAYFOCUS on #EmergingLeader A/Prof Jason Wu @Dr_WuJ from the @georgeinstitute.

Jason is a nutrition scientist focusing on diet and health, and encouraging policy and system changes to help people eat healthier diets in Australia and other countries.


Congrats for important study ⁦@BakerResearchAu⁩ Prof David Kaye and team ....Modest gain from milrinone in HFpEF pilot study. ⁦@TheBHF⁩ ⁦@thecsanz⁩ ⁦@MonashHealth⁩ ⁦@WARC_USYD⁩ ⁦@CircAHA⁩